CAMP4 THERAPEUTICS CORPORATION

CAMP
$4.43 (+ $0.09 + 2.07%)
Last updated: 2026-07-03 23:08 UTC
CAMP Metrics
Exchange
🇺🇸 NASDAQ XNMS
Nasdaq/NMS (Global Market)United StatesAmerica/New_York
SectorHealthcare
IndustryBiotechnology
ISINUS13463J1016
CUSIP13463J101
Market Price4.43
Dividend Yield N/A
Dividend Growth
1YN/A
3YN/A
5YN/A
10YN/A
Annual Dividend N/A
Latest Payout ($)N/A
Latest Payout DateN/A
Dividend FrequencyNone
P/E RatioN/A
EPS-10.85
Market Cap$308.2M
Book Value1.25
Price to Book4.748
BetaN/A
52w High7.3
52w Low1.3
Next Earnings DateN/A

CAMP4 THERAPEUTICS CORPORATION trades under ticker CAMP on NASDAQ as a stock. Use this page to review stock price, dividends, and price history. The page also shows Healthcare exposure. Identifiers: ISIN US13463J1016, CUSIP 13463J101.

About the Company
Camp4 Therapeutics Corporation, a clinical-stage biopharmaceutical company, discovers and develops regulatory RNA-based therapeutics to treat a range of genetic diseases. Its lead product candidate is CMP-CPS-001, which is in a Phase 1 clinical trial for the treatment of urea cycle disorders. The company also develops CMP-SYNGAP for the treatment of SYNGAP1-related disorders. Camp4 Therapeutics Corporation was formerly known as Marauder Therapeutics, Inc. and changed its name to Camp4 Therapeutics Corporation in March 2018. The company was incorporated in 2015 and is headquartered in Cambridge, Massachusetts.
Price History